Treatment of cholinergic‐induced status epilepticus with polytherapy targeting GABA and glutamate receptors
Abstract Despite new antiseizure medications, the development of cholinergic‐induced refractory status epilepticus (RSE) continues to be a therapeutic challenge as pharmacoresistance to benzodiazepines and other antiseizure medications quickly develops. Studies conducted by Epilepsia. 2005;46:142 de...
Main Authors: | Jerome Niquet, Donna Nguyen, Marcio deAraujo Furtado, Lucille Lumley |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-05-01
|
Series: | Epilepsia Open |
Subjects: | |
Online Access: | https://doi.org/10.1002/epi4.12713 |
Similar Items
-
Simultaneous triple therapy for the treatment of status epilepticus
by: Jerome Niquet, et al.
Published: (2017-08-01) -
Antiseizure and Neuroprotective Efficacy of Midazolam in Comparison with Tezampanel (LY293558) against Soman-Induced Status Epilepticus
by: Taiza H. Figueiredo, et al.
Published: (2022-07-01) -
The efficacy and safety of ketamine in refractory and super-refractory status epilepticus: a systemic review
by: Khaled abdullah alzahrani, et al.
Published: (2023-06-01) -
Rational polytherapy in the treatment of cholinergic seizures
by: Jerome Niquet, et al.
Published: (2020-01-01) -
Refractory and Super-Refractory Status Epilepticus in Nerve Agent-Poisoned Rats Following Application of Standard Clinical Treatment Guidelines
by: Julia E. Morgan, et al.
Published: (2021-09-01)